These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 3708566

  • 1. Antitumor activity and biochemical effects of cyclopentenyl cytosine in mice.
    Moyer JD, Malinowski NM, Treanor SP, Marquez VE.
    Cancer Res; 1986 Jul; 46(7):3325-9. PubMed ID: 3708566
    [Abstract] [Full Text] [Related]

  • 2. Resistance to cyclopentenylcytosine in murine leukemia L1210 cells.
    Zhang H, Cooney DA, Zhang MH, Ahluwalia G, Ford H, Johns DG.
    Cancer Res; 1993 Dec 01; 53(23):5714-20. PubMed ID: 7694793
    [Abstract] [Full Text] [Related]

  • 3. Reversal by cytidine of cyclopentenyl cytosine-induced toxicity in mice without compromise of antitumor activity.
    Ford H, Driscoll JS, Hao Z, Dobyns KA, Rommel ME, Stowe E, Anderson JO, Plowman J, Waud WR, Johns DG.
    Biochem Pharmacol; 1995 Jan 18; 49(2):173-80. PubMed ID: 7840794
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesis.
    Kinahan JJ, Pavelic ZP, Leonard RJ, Bloch A, Grindey GB.
    Cancer Res; 1980 Mar 18; 40(3):598-603. PubMed ID: 7471080
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts.
    Blaney SM, Grem JL, Balis FM, Cole DE, Adamson PC, Poplack DG.
    Biochem Pharmacol; 1993 Apr 06; 45(7):1493-501. PubMed ID: 8471071
    [Abstract] [Full Text] [Related]

  • 6. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM, Rustum YM.
    Cancer Res; 1985 Dec 06; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [Abstract] [Full Text] [Related]

  • 7. Uridine and cytidine metabolism following inhibition of de novo pyrimidine synthesis by pyrazofurin.
    Cadman E, Benz C.
    Biochim Biophys Acta; 1980 Oct 17; 609(3):372-82. PubMed ID: 7437431
    [Abstract] [Full Text] [Related]

  • 8. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR, Campbell J, Rustum YM.
    Cancer Treat Rep; 1983 Jun 17; 67(6):547-54. PubMed ID: 6190558
    [Abstract] [Full Text] [Related]

  • 9. Studies on the antitumor activity and biochemical actions of cyclopentenyl cytosine against human colon carcinoma HT-29 in vitro and in vivo.
    Gharehbaghi K, Zhen W, Fritzer-Szekeres M, Szekeres T, Jayaram HN.
    Life Sci; 1999 Jun 17; 64(2):103-12. PubMed ID: 10069488
    [Abstract] [Full Text] [Related]

  • 10. Metabolism and RNA incorporation of cyclopentenyl cytosine in human colorectal cancer cells.
    Yee LK, Allegra CJ, Trepel JB, Grem JL.
    Biochem Pharmacol; 1992 Apr 01; 43(7):1587-99. PubMed ID: 1567480
    [Abstract] [Full Text] [Related]

  • 11. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
    Brockman RW, Shaddix SC, Williams M, Nelson JA, Rose LM, Schabel FM.
    Ann N Y Acad Sci; 1975 Aug 08; 255():501-21. PubMed ID: 171997
    [Abstract] [Full Text] [Related]

  • 12. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT, Johnson RK, Kline I, Vadlamudi S, Gang M, Venditti JM, Goldin A.
    Cancer Treat Rep; 1976 Sep 08; 60(9):1347-61. PubMed ID: 797450
    [Abstract] [Full Text] [Related]

  • 13. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K, Oka T, Morimoto M.
    Cancer Res; 1987 Mar 15; 47(6):1516-22. PubMed ID: 2434218
    [Abstract] [Full Text] [Related]

  • 14. Synthesis of two cyclopentenyl-3-deazapyrimidine carbocyclic nucleosides related to cytidine and uridine.
    Copp RR, Marquez VE.
    J Med Chem; 1991 Jan 15; 34(1):208-12. PubMed ID: 1992119
    [Abstract] [Full Text] [Related]

  • 15. Nucleosides and nucleotides. 180. Synthesis and antitumor activity of nucleosides that have a hydroxylamino group instead of a hydroxyl group at the 2'- or 3'-position of the sugar moiety.
    Ogawa A, Tanaka M, Sasaki T, Matsuda A.
    J Med Chem; 1998 Dec 03; 41(25):5094-107. PubMed ID: 9836625
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
    Li LH, Wallace TL, Richard KA, Tracey DE.
    Cancer Res; 1985 Feb 03; 45(2):532-8. PubMed ID: 3967227
    [Abstract] [Full Text] [Related]

  • 17. Cytidine 5'-triphosphate synthetase as a target for inhibition by the antitumor agent 3-deazauridine.
    McPartland RP, Wang MC, Bloch A, Weinfeld H.
    Cancer Res; 1974 Nov 03; 34(11):3107-11. PubMed ID: 4472653
    [No Abstract] [Full Text] [Related]

  • 18. Modulation of thiol pools by vitamin K3 and its effect on survival of sensitive and resistant murine tumor cells.
    Parekh H, Chavan S, Chitnis M.
    Anticancer Drugs; 1991 Apr 03; 2(2):159-68. PubMed ID: 1683589
    [Abstract] [Full Text] [Related]

  • 19. Cellular pharmacology of cyclopentenyl cytosine in Molt-4 lymphoblasts.
    Ford H, Cooney DA, Ahluwalia GS, Hao Z, Rommel ME, Hicks L, Dobyns KA, Tomaszewski JE, Johns DG.
    Cancer Res; 1991 Jul 15; 51(14):3733-40. PubMed ID: 1712247
    [Abstract] [Full Text] [Related]

  • 20. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV, Wallace RE, Murdock KC, Angier RB, Durr FE, Forbes M.
    Cancer Res; 1982 Feb 15; 42(2):440-4. PubMed ID: 7055799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.